BioSpace News Archive

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, announced today that it has publicly filed an F-1 Registration Statement (File No.: 333-260338) with the U.S. Securities and Exchange Commission relating to a proposed U.S. initial public offering.

SPR Therapeutics® has obtained clearance from the U.S. Food and Drug Administration (FDA) of a broader indication for use for its SPRINT Peripheral Nerve Stimulation (PNS) System.

Rosalind Franklin University of Medicine and Science researcher William Frost, PhD, director of the Stanson Toshok Center for Brain Function and Repair within the university’s Brain Science Institute, has been awarded a $1.95 million grant from the National Institutes of Health to study how the brain develops and sustains focus when responding to novel stimuli.

TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced its Trial Interactive eClinical innovation team will be leading and participating in three TMF-focused sessions at the 10th Annual Trial Master File Summit.

Triple Ring Technologies, a co-development firm that helps innovators and entrepreneurs develop breakthrough science-based technologies, is pleased to announce that the company has been awarded an SBIR Phase I grant by the Food and Drug Administration entitled An e-beam sterilization dose map simulation tool.

Lennart Mucke, MD, founding director of the Gladstone Institute of Neurological Disease and senior investigator at Gladstone Institutes, has been elected to the National Academy of Medicine.

Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced executive leadership changes that reflect the company’s growth and plans for advancing minimally invasive care globally.

Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced financial results for the quarter ended September 30, 2021.